REG-Borregaard ASA: All-time high EBITDA1 of NOK 557 million in the 3rd quarter
Key Highlights
- ➤EBITDA reached all-time high NOK 557 million, versus NOK 440 million
- ➤Operating revenues increased to NOK 1,894 million, versus NOK 1,799 million
- ➤All business areas reported higher results than in the third quarter of 2025
- ➤Profit before tax rose to NOK 394 million, versus NOK 247 million
- ➤Earnings per share increased to NOK 2.96, versus NOK 1.96
Expert Statements
Tom Erik Foss-Jacobsen, CEO of Borregaard
“Borregaard delivered an all-time high quarterly EBITDA with higher results across all business areas, strong operational performance at the Sarpsborg biorefinery, savings from the cost improvement programme, optimisation of our energy system, and selective price increases”
Borregaard’s operating revenues increased to NOK 1,894 million (NOK 1,799 million) in the 3(rd) quarter of 2026. EBITDA(1) reached an all-time high of NOK 557 million (NOK 440 million). The results in all areas increased compared with the 3(rd) quarter of 2025.
In BioSolutions, selective price increases and reduced costs were the main reasons for the improved result. Higher deliveries and strong production were the main reasons for an all-time high result in BioMaterials. In Fine Chemicals, the result improved due to higher deliveries of both fine chemical intermediates and bioethanol. Savings from the ongoing cost improvement programme and energy system optimisation contributed positively to the Group’s results in the quarter. Net currency effects were positive for the Group.
Get started
Create a free account to read the full story.